Deutenzalutamide

DRUG2 trials

Sponsors

AstraZeneca, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions

Metastatic Castration-resistant Prostate CancerProstate Cancer (Adenocarcinoma)

Phase 2

Deutenzalutamide and Hormone Therapy Before and After Surgery With Docetaxel Before Surgery for High-Risk Localized or Locally Advanced Prostate Cancer

Not yet recruitingNCT07907653

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityProstate Cancer (Adenocarcinoma)

Start: 2026-11-01End: 2035-01-01Target: 37Updated: 2026-10-30

Phase 3

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

RecruitingNCT07611110

AstraZenecaMetastatic Castration-resistant Prostate Cancer

Start: 2026-05-04End: 2030-06-06Target: 670Updated: 2026-10-19